TY - JOUR
T1 - Clinical and Genetic Characteristics of East Asian Patients with Occult Macular Dystrophy (Miyake Disease)
T2 - East Asia Occult Macular Dystrophy Studies Report Number 1
AU - Fujinami, Kaoru
AU - Yang, Lizhu
AU - Joo, Kwangsic
AU - Tsunoda, Kazushige
AU - Kameya, Shuhei
AU - Hanazono, Gen
AU - Fujinami-Yokokawa, Yu
AU - Arno, Gavin
AU - Kondo, Mineo
AU - Nakamura, Natsuko
AU - Kurihara, Toshihide
AU - Tsubota, Kazuo
AU - Zou, Xuan
AU - Li, Hui
AU - Park, Kyu Hyung
AU - Iwata, Takeshi
AU - Miyake, Yozo
AU - Woo, Se Joon
AU - Sui, Ruifang
N1 - Funding Information:
S.J.W.: Paid consultant – Samsung Bioepis Inc, South Korea; Co-founder of Retimark Inc, South Korea; Research grant – Seoul National University Bundang Hospital (02-2017-059), National Research Foundation of Korea grant 2016R1D1A1B03934724, funded by the Korean government (Ministry of Science, ICT and Future Planning [MSIP]). Financial Disclosure(s): The author(s) have made the following disclosure(s): Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor but may receive salary or other support from the institution to support their effort on the project(s). K.F.: Paid consultant – Astellas Pharma Inc, Kubota Pharmaceutical Holdings Co, Ltd, Acucela Inc, Novartis AG, NightstaRx Limited; Personal fees – Astellas Pharma Inc, Kubota Pharmaceutical Holdings Co, Ltd, Acucela Inc, Novartis AG, Santen Company Limited, Foundation Fighting Blindness, Foundation Fighting Blindness Clinical Research Institute, Japanese Ophthalmology Society, Japan Retinitis Pigmentosa Society; Grants – Astellas Pharma Inc. (NCT03281005), outside the submitted work; Grant-in-Aid for Young Scientists (A) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (16H06269), Grant-in-Aid for Scientists to support international collaborative studies of the Ministry of Education, Culture, Sports, Science and Technology, Japan (16KK01930002), National Hospital Organization Network Research Fund, Japan (H30-NHO-Sensory Organs-03), Foundation Fighting Blindness Alan Laties Career Development Program (CF-CL-0416-0696-UCL), USA; Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare, Japan (201711107A), Great Britain Sasakawa Foundation Butterfield Awards, UK. K.T.: Support – Japan Agency for Medical Research and Development, the Ministry of Health, Labor and Welfare, Japan (18ek0109282h0002); Grants – for Scientific Research, Japan Society for the Promotion of Science, Japan (H26-26462674). Y.F.-Y.: Grants – Grant-in-Aid for Young Scientists of the Ministry of Education, Culture, Sports, Science and Technology, Japan (18K16943). G.A.: Support – Fight for Sight (UK) Early Career Investigator award, NIHR-BRC at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, and Great Britain Sasakawa Foundation Butterfield Award, UK. R.S.: Grants – Foundation Fighting Blindness (CD-CL-0214-0631-PUMCH); CAMS Innovation Fund for Medical Sciences, China, CIFMS 2016-12M-1-002; National Natural Science Foundation of China, China, 81470669. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Obtained funding: Fujinami, Tsunoda, Fujinami-Yokokawa, Arno, Kurihara, Tsubota, Iwata, Woo, Sui
Publisher Copyright:
© 2019 American Academy of Ophthalmology
PY - 2019/10
Y1 - 2019/10
N2 - Purpose: To describe the clinical and genetic characteristics of the cohort enrolled in the East Asian studies of occult macular dystrophy (OMD). Design: International, multicenter, retrospective cohort studies. Participants: A total of 36 participants from 21 families with a clinical diagnosis of OMD and harboring pathogenic RP1L1 variants (i.e., Miyake disease) were enrolled from 3 centers in Japan, China, and South Korea. Methods: A detailed history was obtained, and comprehensive ophthalmological examinations including spectral-domain OCT were performed. All detected sequence variants in the RP1L1 gene were reviewed, and in silico analysis was performed, including allele frequency analyses and pathogenicity predictions. Main Outcome Measures: Onset of disease, visual acuity (VA) converted to the logarithm of the minimum angle of resolution (logMAR), OCT findings, and effect of detected variants. Results: Eleven families from Japan, 6 from South Korea, and 4 from China were recruited. There were 12 female and 24 male participants. The median age of onset was 25.5 years (range, 2–73), and the median age at the latest examination was 46.0 years (range, 11–86). The median VA (logMAR) was 0.65 (range, –0.08–1.22) in the right eye and 0.65 (–0.08–1.10) in the left eye. A significant correlation between onset of disease and VA was revealed. The Classical morphologic phenotype showing both blurred ellipsoid zone and absence of interdigitation zone of the photoreceptors was demonstrated in 30 patients (83.3%), and subtle photoreceptor architectural changes were demonstrated in 6 patients (16.6%). Eight pathogenic RP1L1 variants were identified, including 6 reported variants and 1 novel variant: p.R45W, p.T1194M/p.T1196I (complex), p.S1199C, p.G1200A, p.G1200D, p.V1201G, and p.S1198F, respectively. Two variants were recurrent: p.R45W (11 families, 52.4%) and p.S1199C (5 families, 23.8%). The pathogenic missense variants in 10 families (47.6%) were located within the previously reported unique motif, including 6 amino acids (1196–1201). Conclusions: There is a large spectrum of clinical findings in Miyake disease, including various onset of disease and VA, whereas the characteristic photoreceptor microstructures were shared in most cases. Two hot spots including amino acid numbers 45 and 1196–1201 in the RP1L1 gene were confirmed in the East Asian population.
AB - Purpose: To describe the clinical and genetic characteristics of the cohort enrolled in the East Asian studies of occult macular dystrophy (OMD). Design: International, multicenter, retrospective cohort studies. Participants: A total of 36 participants from 21 families with a clinical diagnosis of OMD and harboring pathogenic RP1L1 variants (i.e., Miyake disease) were enrolled from 3 centers in Japan, China, and South Korea. Methods: A detailed history was obtained, and comprehensive ophthalmological examinations including spectral-domain OCT were performed. All detected sequence variants in the RP1L1 gene were reviewed, and in silico analysis was performed, including allele frequency analyses and pathogenicity predictions. Main Outcome Measures: Onset of disease, visual acuity (VA) converted to the logarithm of the minimum angle of resolution (logMAR), OCT findings, and effect of detected variants. Results: Eleven families from Japan, 6 from South Korea, and 4 from China were recruited. There were 12 female and 24 male participants. The median age of onset was 25.5 years (range, 2–73), and the median age at the latest examination was 46.0 years (range, 11–86). The median VA (logMAR) was 0.65 (range, –0.08–1.22) in the right eye and 0.65 (–0.08–1.10) in the left eye. A significant correlation between onset of disease and VA was revealed. The Classical morphologic phenotype showing both blurred ellipsoid zone and absence of interdigitation zone of the photoreceptors was demonstrated in 30 patients (83.3%), and subtle photoreceptor architectural changes were demonstrated in 6 patients (16.6%). Eight pathogenic RP1L1 variants were identified, including 6 reported variants and 1 novel variant: p.R45W, p.T1194M/p.T1196I (complex), p.S1199C, p.G1200A, p.G1200D, p.V1201G, and p.S1198F, respectively. Two variants were recurrent: p.R45W (11 families, 52.4%) and p.S1199C (5 families, 23.8%). The pathogenic missense variants in 10 families (47.6%) were located within the previously reported unique motif, including 6 amino acids (1196–1201). Conclusions: There is a large spectrum of clinical findings in Miyake disease, including various onset of disease and VA, whereas the characteristic photoreceptor microstructures were shared in most cases. Two hot spots including amino acid numbers 45 and 1196–1201 in the RP1L1 gene were confirmed in the East Asian population.
UR - http://www.scopus.com/inward/record.url?scp=85066474888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066474888&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2019.04.032
DO - 10.1016/j.ophtha.2019.04.032
M3 - Article
C2 - 31028767
AN - SCOPUS:85066474888
SN - 0161-6420
VL - 126
SP - 1432
EP - 1444
JO - Ophthalmology
JF - Ophthalmology
IS - 10
ER -